Earnings calendar/ELTX
Elicio Therapeutics, Inc. (ELTX)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Latest EPS YoY
+34.8%
vs 2025-08-07
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$0
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 13, 2026
EPS beat
EPS actual / est
$-0.43 / $-0.54
+20.0%
Revenue actual / est
$0 / —
—
Result
Target reached
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/13/2026 | $-0.54 | $-0.43 | +20.0% | — | $0 | — |
| 8/6/2026 | $-0.54 | $-0.43 | +20.0% | — | $0 | — |
| 5/12/2026upcoming | $-0.49 | Pending | — | — | Pending | — |
| 5/11/2026 | $-0.49 | $-0.65 | -32.7% | — | Pending | — |
| 3/30/2026upcoming | $-0.58 | Pending | — | — | Pending | — |
| 3/12/2026 | $-0.47 | $-0.49 | -4.3% | — | Pending | — |
| 11/13/2025 | $-0.62 | $-0.60 | +3.2% | — | Pending | — |
| 8/7/2025 | $-0.69 | $-0.66 | +4.3% | — | Pending | — |
| 5/13/2025 | $-0.67 | $-0.87 | -29.9% | — | Pending | — |
| 3/31/2025 | $-0.94 | $-1.02 | -8.5% | — | $1.2M | — |
| 11/13/2024 | $-0.81 | $-1.39 | -71.6% | — | Pending | — |
| 8/13/2024 | $-0.96 | $-0.64 | +33.3% | — | Pending | — |
| 5/15/2024 | $-1.09 | $-1.15 | -5.5% | — | Pending | — |
| 2/13/2024 | $-0.78 | $-1.75 | -124.4% | — | Pending | — |
| 11/9/2023 | $-0.80 | $-1.27 | -58.7% | — | Pending | — |
| 8/11/2023 | $-5.70 | $-2.61 | +54.2% | $800,000 | Pending | — |
| 5/10/2023 | $-0.54 | $-0.15 | +72.2% | $800,000 | Pending | — |
| 12/31/2022 | — | $-2.15 | — | — | Pending | — |
| 12/30/2022 | — | $-2.15 | — | — | Pending | — |
| 9/30/2022 | $-3.20 | $-2.27 | +29.2% | $625,000 | Pending | — |
Need ELTX data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.